CVE-2022-1517 is a critical vulnerability affecting Illumina iSeq 100, Local Run Manager, MiniSeq, MiSeq, MiSeqDx, NextSeq 500, NextSeq 550, and NextSeq 550Dx devices, where the Local Run Manager (LRM) uses elevated privileges. This allows an unauthenticated attacker to remotely upload and execute arbitrary code at the operating system level. With a CVSS score of 9.8 (Critical), the vulnerability has a low attack complexity and no user interaction required, enabling full compromise of confidentiality, integrity, and availability. While there is no known active exploitation or public exploit code (Metasploit, Nuclei, ExploitDB), the vulnerability has garnered significant community attention with 11 mentions and media coverage from SecurityWeek.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
>= 1.3, <= 3.1CPE matchmatch criteria | cpe:2.3:a:illumina:local_run_manager:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.3 Bluesky, 0.3 Mastodon, and 2.4 GitHub mentions.
The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.